Literature DB >> 420524

Isoniazid liver injury during chemoprophylaxis in children.

P Spyridis, C Sinaniotis, I Papadea, L Oreopoulos, S Hadjiyiannis, C Papadatos.   

Abstract

The incidence of INH-associated liver injury was evaluated in 239 children aged between 9 and 14 years, who were receiving 300 mg INH/day for tuberculosis prophylaxis. Serum SGOT and SGPT levels were determined before INH administration and at 4-weekly intervals thereafter. Levels of both enzymes were raised during the first 3 months of treatment in 18 (7.5%) children, while in 23 (9.6%) children either SGOT or SGPT exceeded normal levels (SGOT greater than 40 units, SGPT greater than 30 units). Only 2 (0.8%) children showed SGOT and SGPT values above 100 units and in them treatment with INH had to be discontinued. In all other children transaminases returned to normal during uninterrupted INH administration. It was noted also that transaminase values in children who did not exhibit a rise above normal, still had significantly higher levels during treatment compared with before. The findings of this study suggest that liver injury in children receiving INH for prophylaxis occurs more often than it had hitherto been believed but that it is usually mild and transient.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420524      PMCID: PMC1545216          DOI: 10.1136/adc.54.1.65

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.

Authors:  S REITMAN; S FRANKEL
Journal:  Am J Clin Pathol       Date:  1957-07       Impact factor: 2.493

2.  Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15-year-old girl.

Authors:  J A Vanderhoof; M E Ament
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

3.  Liver enzyme disturbances during isoniazid chemoprophylaxis in children.

Authors:  P H Beaudry; H F Brickman; M B Wise; D MacDougall
Journal:  Am Rev Respir Dis       Date:  1974-11

4.  Isoniazid administration and liver injury.

Authors:  R Rudoy; J Stuemky; J R Poley
Journal:  Am J Dis Child       Date:  1973-05

5.  Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.

Authors:  W C Bailey; S L Taylor; H E Dascomb; H B Greenberg; M M Ziskind
Journal:  Am Rev Respir Dis       Date:  1973-04

6.  Isoniazid-associated hepatitis. Report of an outbreak.

Authors:  R A Garibaldi; R E Drusin; S H Ferebee; M B Gregg
Journal:  Am Rev Respir Dis       Date:  1972-09

7.  Isoniazid toxicity. A prospective study in secondary chemoprophylaxis.

Authors:  C B Byrd; R Nelson; R C Elliott
Journal:  JAMA       Date:  1972-06-12       Impact factor: 56.272

8.  Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.

Authors:  L Scharer; J P Smith
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

9.  Isoniazid hepatitis in adolescents.

Authors:  I F Litt; M I Cohen; H McNamara
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

Review 10.  Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.

Authors:  J R Mitchell; H J Zimmerman; K G Ishak; U P Thorgeirsson; J A Timbrell; W R Snodgrass; S D Nelson
Journal:  Ann Intern Med       Date:  1976-02       Impact factor: 25.391

View more
  9 in total

1.  Antituberculous therapy in children.

Authors:  V Seth
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

2.  Successful liver transplantation for isoniazid-induced hepatic failure--a case report.

Authors:  T Hasagawa; J Reyes; B Nour; A G Tzakis; M Green; S Todo; T E Starzl
Journal:  Transplantation       Date:  1994-04-27       Impact factor: 4.939

Review 3.  Tuberculosis: evidence review for newly arriving immigrants and refugees.

Authors:  Christina Greenaway; Amelia Sandoe; Bilkis Vissandjee; Ian Kitai; Doug Gruner; Wendy Wobeser; Kevin Pottie; Erin Ueffing; Dick Menzies; Kevin Schwartzman
Journal:  CMAJ       Date:  2010-07-15       Impact factor: 8.262

4.  Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.

Authors:  S R Salpeter
Journal:  West J Med       Date:  1993-11

Review 5.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

Review 6.  Treatment of tuberculous infection and disease in children: the North American perspective.

Authors:  C D Stowe; R F Jacobs
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.930

7.  Antituberculosis drug-induced hepatotoxicity in children.

Authors:  Peter R Donald
Journal:  Pediatr Rep       Date:  2011-06-16

8.  Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation.

Authors:  Merrin E Rutherford; Rovina Ruslami; Winni Maharani; Indria Yulita; Sarah Lovell; Reinout Van Crevel; Bachti Alisjahbana; Philip C Hill
Journal:  BMC Res Notes       Date:  2012-01-06

9.  Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany.

Authors:  Stephanie Thee; Renate Krüger; Horst von Bernuth; Christian Meisel; Uwe Kölsch; Valerie Kirchberger; Cornelia Feiterna-Sperling
Journal:  PLoS One       Date:  2019-05-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.